1. Home
  2. NTWK vs MREO Comparison

NTWK vs MREO Comparison

Compare NTWK & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$4.08

Market Cap

50.6M

Sector

Technology

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.27

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
MREO
Founded
1997
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
50.3M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
NTWK
MREO
Price
$4.08
$0.27
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$1.50
AVG Volume (30 Days)
15.4K
4.9M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
316.67
16.67
EPS
N/A
N/A
Revenue
$73,088,687.00
$500,000.00
Revenue This Year
N/A
$5,184.20
Revenue Next Year
N/A
$55.51
P/E Ratio
N/A
N/A
Revenue Growth
13.40
N/A
52 Week Low
$2.73
$0.20
52 Week High
$5.75
$2.37

Technical Indicators

Market Signals
Indicator
NTWK
MREO
Relative Strength Index (RSI) 48.21 41.21
Support Level $2.94 $0.22
Resistance Level $4.53 $0.35
Average True Range (ATR) 0.11 0.02
MACD 0.01 -0.00
Stochastic Oscillator 58.37 23.45

Price Performance

Historical Comparison
NTWK
MREO

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: